Rare diseases
Investigational molecules
Locations
Back to Poland16 clinical trials in Dabrowa Gornicza, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
PolandStudy on Metformin's Effect in Reducing Unplanned Heart Procedures in Non-Diabetic Patients with Acute Coronary Syndrome
PolandStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
PolandStudy of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
PolandStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
PolandA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
PolandStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
PolandStudy on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia
PolandA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandStudy on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure
PolandStudy on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on SGLT-2 inhibitors for patients with acute heart failure, examining treatment effectiveness across different ejection fraction types.
Research aims to enhance patient care regardless of diabetes status.
Advanced trials investigating novel therapies for atherosclerotic cardiovascular disease, focusing on preventing major adverse cardiovascular events.
Studies evaluate innovative compounds to reduce cardiovascular risks in high-risk populations.
Comprehensive research on acute coronary syndrome treatments, including antiplatelet therapy strategies and metabolic interventions.
Trials focus on optimizing treatment approaches for better patient outcomes.
Studies examining new treatments for atrial fibrillation, comparing novel anticoagulants with established therapies for safety and effectiveness.
Research aims to improve safety profiles of cardiac rhythm treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
